COLUMBUS, Ohio, June 27, 2025 /PRNewswire/ — Huntington Bancshares Incorporated announced that the Board of Directors declared and set aside a quarterly cash dividend on the company’s 5.70% Series I Non-Cumulative Perpetual Preferred Stock (Nasdaq: HBANM) of $356.25 per share (equivalent to $0.35625 per depositary share) payable September 2, 2025, to shareholders of record on […]
NEW YORK, June 27, 2025 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Apple Inc. (“Apple” or “the Company”) (NASDAQ: AAPL) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations
HOUSTON, June 27, 2025 /PRNewswire/ — Galindo Law is proud to celebrate 25 years of delivering justice to the people impacted by hurricanes, storms, personal injury accidents, and other disasters. Since opening its doors in 2000, the Houston-based firm has become a trusted name in the community while handling thousands of cases and recovering hundreds
Galindo Law Marks 25 Years of Fighting for The People Read Post »
PressNEW YORK, June 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Edgewise and certain of its officers and/or directors have engaged in securities fraud or
NEW YORK, June 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Altimmune and certain of its officers and/or directors have engaged in securities fraud or other
NEW YORK, June 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”)(NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number,
NEW YORK, June 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Tesla and certain of its officers and/or directors have engaged in securities fraud or other
NEW YORK, June 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
